Caribou’s Phase I CAR-T Data In Lymphoma Show Improvement In Durability

 
• By Alaric DeArment
  
Caribou announced updated Phase I data from the ANTLER trial of allogeneic CAR-T CB-010 in non-Hodgkin lymphomas • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D